# Pierre Fabre Medicament - Inspection Records

Source: https://www.globalkeysolutions.net/companies/pierre-fabre-medicament/6c1f31d4-d9f5-478e-99f6-4a0b18be71b5

> Inspection records and compliance data for Pierre Fabre Medicament in Gaillac, None. Access full analysis and detailed observations.

---

## Details

- Name: Pierre Fabre Medicament
- FEI Number: 3002807889
- City: Gaillac
- State: None
- Country Name: France
- Address Line 1: Zone Industrielle de Clergous, 16 rue Jean Rostand
- Zip Code: None

## Related Documents

- [FDA Inspection 1287242 - Pierre Fabre Medicament - 2022-07-08](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/7b202fe2-cbe7-4cf2-9f48-14ef3b34b38d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 8, 2022
- [FDA Inspection 1094312 - Pierre Fabre Medicament - 2018-07-13](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/57dd8a98-078f-4304-9180-b54ea9c3f9c7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 13, 2018
- [FDA Inspection 970600 - Pierre Fabre Medicament - 2016-04-15](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/22e19e7c-24ab-4fd4-9b4e-8f60ed51f9e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2016
- [FDA Inspection 822697 - Pierre Fabre Medicament - 2013-03-14](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-medicament/1f1c80d6-dba7-419b-8096-2caf80c9f80c) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2013

## Related Companies

- [Ingredion Incorporated](https://www.globalkeysolutions.net/companies/ingredion-incorporated/682134aa-702a-4956-8caa-c79b25f59948)
- [Pfanstiehl, Inc](https://www.globalkeysolutions.net/companies/pfanstiehl-inc/970291ff-e456-4b46-b5f5-20c57b331665)
- [BioMimetic Therapeutics, LLC](https://www.globalkeysolutions.net/companies/biomimetic-therapeutics-llc/a8a0027c-d16c-42dd-bfe0-22d536602148)
- [Tomita Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/tomita-pharmaceutical-co-ltd/01c2e59a-b579-43f4-a73d-527ad6021b2b)
- [Jiangsu Lianhuan Pharmaceutical Co., Ltd](https://www.globalkeysolutions.net/companies/jiangsu-lianhuan-pharmaceutical-co-ltd/6ad4f52f-348f-4e7e-9539-7e51d3583927)
- [Aino Co., Ltd. of North China Pharma. Group](https://www.globalkeysolutions.net/companies/aino-co-ltd-of-north-china-pharma-group/e6d7882f-44c2-4550-bbec-b76d137da6f2)
- [US Salt LLC](https://www.globalkeysolutions.net/companies/us-salt-llc/46aa9dcc-39ce-4415-bc25-6da709feb341)
- [Fujian Fukang Pharmaceutical Co., Ltd](https://www.globalkeysolutions.net/companies/fujian-fukang-pharmaceutical-co-ltd/1cea7fe1-88a5-4b17-9374-cb48d4391f42)
- [Hydrite Chemical Co.](https://www.globalkeysolutions.net/companies/hydrite-chemical-co/6a8e1ad7-5edc-4603-afd8-6ecdecf3074a)
- [Peptido GmbH](https://www.globalkeysolutions.net/companies/peptido-gmbh/2faf665d-43ee-4699-8357-173992a6fc97)
